The effect of subarachnoid sodium nitroprusside on the prevention of vasospasm in subarachnoid haemorrhage

Acta Neurochirurgica, Supplementum

Volumn , Issue 95, 2005, Pages 141-145

  Pachl, J ^a   Haninec, P ^a   Tencer, T ^a   Mizner, P ^a   Houst'Ava L ^a   Tomas R ^a   Waldauf, P ^a  

^a CHARLES UNIVERSITY   (Czech Republic)

Author keywords

multimodal brain monitoring; Prevention of delayed vasospasm; subarachnoid haemorrhage; subarachnoid nitroprusside sodium administration

Indexed keywords

NITROPRUSSIDE SODIUM; VASODILATOR AGENT;

ADULT; AGED; ARTICLE; BRAIN VASOSPASM; CATHETERIZATION; CLINICAL TRIAL; DRUG EFFECT; FEMALE; HUMAN; INTRACEREBROVENTRICULAR DRUG ADMINISTRATION; MALE; METHODOLOGY; MIDDLE AGED; SUBARACHNOID HEMORRHAGE; SUBARACHNOID SPACE; TREATMENT OUTCOME;

ADULT; AGED; CATHETERIZATION; FEMALE; HUMANS; INJECTIONS, INTRAVENTRICULAR; MALE; MIDDLE AGED; NITROPRUSSIDE; SUBARACHNOID HEMORRHAGE; SUBARACHNOID SPACE; TREATMENT OUTCOME; VASODILATOR AGENTS; VASOSPASM, INTRACRANIAL;

EID: 85052610149     PISSN: 00651419     EISSN: None     Source Type: Book Series    
DOI: 10.1007/3-211-32318-X_31     Document Type: Conference Paper

References (13)

1. Aasled R, Hubert P, Nornes H (1986) A transcranial Doppler method for the evaluation of cerebrovascular spasm. Neuroradiology 28:11-16 (Pubitemid 16146458)
2. Charbel FT, Du X, Hoffman WE, Ausman JI (2002) Brain tissue PO (2), PCO (2), and pH during cerebral vasospasm. J Neurosurg 97(6):1302-1305
3. Dorsch N (2002) Therapeutic approaches to vasospasm in subarachnoid hemorrhage. Curr Opin Crit Care 8:128-133
4. Fitch W, Pickard JD, Tamura A, Graham D (1988) Effects of hypotension induced with sodium nitroprusside on the cerebral circulation before, and one week after, the subarachnoidal injection of blood. J Neurol Neurosurg Psychiatry 51(1):88-93
5. Gabikian P, Clatterbuck RE, Eberhart CG, Tyler BM, Tierney TS, Tamargo RJ (2002) Prevention of experimental cerebral vasospasm by intracranial delivery of a nitric oxide donor from a controlled-release polymer: toxicity and efficacy studies in rabbits and rats. Stroke 33(11):2681-2686
6. Graves EJ (1992) Detailed diagnoses and procedures, National Hospital Discharge Survey. Vital Health Stat 113:1-225
7. Macdonald RL, Zhang ZD, Curry D, Elas M, Aihara Y, Halpern H, Jahromi BS, Johns L (2002) Intracisternal sodium nitroprusside fails to prevent vasospasm in nonhuman primates. Neurosurgery 51(3):761-768; discussion 768-770
8. Pathak A, Mathuriya SN, Khandelwal N, Verma K (2003) Intermittent low dose sodium nitroprusside therapy for treatment of symptomatic aneurysmal SAH-induced vasospasm. Br J Neurosurg 17(4):306-310
9. Raabe A, Zimmermann N (2002) Effect of intraventricular SodiumNitroprusside on cerebral hemodynamics and oxygenation in poor - grade aneurysma patients with severe, medically refractory vasospasm. Neurosurgery 50(5):1006-1013
10. Thomas JE, McGinnis G (2002) Safety of Intraventricular Sodium Nitroprusside and Thiosulfate for the treatment of Cerebral Vasospasm in the Intensive Care Unit. Stroke 33:486-492
11. Thomas JE, Nemirovsky A, Zelman V, Giannotta SL (1997) Rapid reversal of Endothelin-1 induced cerebrál vasoconstriction by intrathecal administration of nitric oxid donors. Neurosurgery 40:1245-1249
12. Thomas JE, Rosenwasser RH (1999) Reversal of severe cerebral vasospasm in three patients after aneurysmal subarachnoid hemorrhage: initial observations regarding the use of intraventricular sodium nitroprusside in humans. Neurosurgery 44:48-57
13. Thomas JE, Rosenwasser RH, Armonda RA (1999) Safety of intrathecal sodium nitroprusside for the treatment and prevention of refractory cerebral vasospasm and ischemia in humans. Stroke 30:1409-1416